{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:58:52Z","timestamp":1781060332991,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"HOPE-EPI","award":["ANR-10-COHO-0009"],"award-info":[{"award-number":["ANR-10-COHO-0009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00520-026-10769-w","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:11:57Z","timestamp":1778490717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sensorineural hearing loss after pediatric cranial radiotherapy: a multicenter analysis of dosimetric and clinical risk factors"],"prefix":"10.1007","volume":"34","author":[{"given":"William","family":"Gehin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Ollivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jouglar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dossun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jolnerovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bernier-Chastagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"11","key":"10769_CR1","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2015.63.6738","volume":"34","author":"JK Bass","year":"2016","unstructured":"Bass JK, Hua CH, Huang J et al (2016) Hearing loss in patients who received cranial radiation therapy for childhood cancer. J Clin Oncol 34(11):1248\u20131255. https:\/\/doi.org\/10.1200\/JCO.2015.63.6738","journal-title":"J Clin Oncol"},{"issue":"3","key":"10769_CR2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.ijrobp.2008.01.050","volume":"72","author":"C Hua","year":"2008","unstructured":"Hua C, Bass JK, Khan R, Kun LE, Merchant TE (2008) Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. Int J Radiat Oncol Biol Phys 72(3):892\u2013899. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.01.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10769_CR3","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/neuonc\/noae114","volume":"26","author":"MH Abu-Arja","year":"2024","unstructured":"Abu-Arja MH, Brown AL, Su JM et al (2024) The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and Cisplatin in children with Medulloblastoma. Neuro Oncol 26(10):1912\u20131920. https:\/\/doi.org\/10.1093\/neuonc\/noae114","journal-title":"Neuro Oncol"},{"issue":"20","key":"10769_CR4","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1002\/cam4.4245","volume":"10","author":"I Moxon-Emre","year":"2021","unstructured":"Moxon-Emre I, Dahl C, Ramaswamy V et al (2021) Hearing loss and intellectual outcome in children treated for embryonal brain tumors: implications for young children treated with radiation sparing approaches. Cancer Med 10(20):7111\u20137125. https:\/\/doi.org\/10.1002\/cam4.4245","journal-title":"Cancer Med"},{"issue":"9","key":"10769_CR5","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1001\/jamaoncol.2020.2822","volume":"6","author":"JK Bass","year":"2020","unstructured":"Bass JK, Liu W, Banerjee P et al (2020) Association of hearing impairment with neurocognition in survivors of childhood cancer. JAMA Oncol 6(9):1363\u20131371. https:\/\/doi.org\/10.1001\/jamaoncol.2020.2822","journal-title":"JAMA Oncol"},{"issue":"5","key":"10769_CR6","doi-asserted-by":"publisher","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","volume":"120","author":"JG Gurney","year":"2007","unstructured":"Gurney JG, Tersak JM, Ness KK et al (2007) Hearing loss, quality of life, and academic problems in long-term Neuroblastoma survivors: a report from the Children\u2019s Oncology Group. Pediatrics 120(5):e1229-1236. https:\/\/doi.org\/10.1542\/peds.2007-0178","journal-title":"Pediatrics"},{"key":"10769_CR7","doi-asserted-by":"publisher","unstructured":"Murphy B, Jackson A, Bass JK et al (2023) Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. Published online October 19 S0360\u20133016(23)07779\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.08.016","DOI":"10.1016\/j.ijrobp.2023.08.016"},{"key":"10769_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110346","volume":"197","author":"W Gehin","year":"2024","unstructured":"Gehin W, Chastagner P, Mansuy L, Bernier-Chastagner V (2024) Dosimetric analysis of hearing loss after cranial radiation therapy in children: a single-institution study from the French national registry PediaRT. Radiother Oncol 197:110346. https:\/\/doi.org\/10.1016\/j.radonc.2024.110346","journal-title":"Radiother Oncol"},{"issue":"5","key":"10769_CR9","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.ijrobp.2021.02.050","volume":"110","author":"S Cohen-Cutler","year":"2021","unstructured":"Cohen-Cutler S, Wong K, Mena V et al (2021) Hearing loss risk in pediatric patients treated with cranial irradiation and Cisplatin-based chemotherapy. Int J Radiat Oncol Biol Phys 110(5):1488\u20131495. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.02.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"34","key":"10769_CR10","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1200\/JCO.21.00899","volume":"39","author":"D Keilty","year":"2021","unstructured":"Keilty D, Khandwala M, Liu ZA et al (2021) Hearing loss after radiation and chemotherapy for CNS and head-and-neck tumors in children. JCO 39(34):3813\u20133821. https:\/\/doi.org\/10.1200\/JCO.21.00899","journal-title":"JCO"},{"issue":"5","key":"10769_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S1470-2045(22)00155-3","volume":"23","author":"E Orgel","year":"2022","unstructured":"Orgel E, Villaluna D, Krailo MD, Esbenshade A, Sung L, Freyer DR (2022) Sodium thiosulfate for prevention of Cisplatin-induced hearing loss: updated survival from ACCL0431. Lancet Oncol 23(5):570\u2013572. https:\/\/doi.org\/10.1016\/S1470-2045(22)00155-3","journal-title":"Lancet Oncol"},{"issue":"1","key":"10769_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","volume":"18","author":"DR Freyer","year":"2017","unstructured":"Freyer DR, Chen L, Krailo MD et al (2017) Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncol 18(1):63\u201374. https:\/\/doi.org\/10.1016\/S1470-2045(16)30625-8","journal-title":"Lancet Oncol"},{"issue":"19","key":"10769_CR13","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","volume":"30","author":"PR Brock","year":"2012","unstructured":"Brock PR, Knight KR, Freyer DR et al (2012) Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol 30(19):2408\u20132417. https:\/\/doi.org\/10.1200\/JCO.2011.39.1110","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10769-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10769-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10769-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:27:59Z","timestamp":1781058479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10769-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10769"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10769-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. It was based on retrospective analysis of data from the French national Pediatric Radiotherapy registry (PediaRT), a health data warehouse (\u201cEntrep\u00f4t de Donn\u00e9es de Sant\u00e9\u201d, EDS) hosted by the Institut de Canc\u00e9rologie de Lorraine and containing dosimetric data from pediatric radiotherapy treatments. The PediaRT registry complies with the French National Commission for Data Protection (CNIL) reference methodology MS-002 (registration number 2231699, conformity date: November 2, 2023). According to French regulations, retrospective studies based on data from a compliant EDS do not require formal approval by an institutional review board or individual informed consent from participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"522"}}